A 139 (Fenofibric Acid Delayed-Release 135 mg)
Pill with imprint A 139 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Alembic Pharmaceuticals Inc..
Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A 139
Fenofibric Acid Delayed-Release
- Imprint
- A 139
- Strength
- 135 mg
- Color
- Blue & Yellow
- Size
- 21.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alembic Pharmaceuticals Inc.
- National Drug Code (NDC)
- 62332-0245
- Inactive Ingredients
-
hypromelloses, povidone k30, water, hydroxypropyl cellulose (type e), silicon dioxide, sodium stearyl fumarate, methacrylic acid, magnesium silicate, triethyl citrate, gelatin, titanium dioxide, ferric oxide yellow, FD&C Blue No. 2, shellac, propylene glycol, potassium hydroxide, ferrosoferric oxide
Note: Inactive ingredients may vary.
Related Images for "A 139"
More about fenofibric acid
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 24 Reviews
- Drug class: fibric acid derivatives
- FDA Alerts (1)
Consumer resources
Other brands: Trilipix, Fibricor
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
